Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras

Paula Saá; Rebecca V. Fink; Hina Dawar; Clara Di Germanio; Leilani Montalvo; David J. Wright; David E. Krysztof; Steven Kleinman; Theresa Nester; Debra Kessler; Rebecca L. Townsend; Bryan R. Spencer; Hany Kamel; Jackie Vannoy; Michael P. Busch; Susan L. Stramer; Mars Stone; Philip J. Norris

doi:10.1093/ofid/ofad253

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Presymptomatic plasma samples from 1596 donors reporting coronavirus disease 2019 infection or symptoms after blood donation were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and anti-S and anti-N antibodies. Prior infection and vaccination both protected from developing SARS-CoV-2 RNAemia and from symptomatic infection. RNAemia rates did not differ in the Delta and Omicron variant eras.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Saá et al. (2023) studied this question.

synapsesocial.com/papers/6a7cd6aa50edcffafcaeb0bf https://doi.org/10.1093/ofid/ofad253

View Full Paper

Ask AI

Bookmark

Share

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras

Ask about this paper

Abstract

Discussion

Cite This Study

Prevalence of SARS-CoV-2 Viremia in Presymptomatic Blood Donors in the Delta and Omicron Variant Eras

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading